|
RPS15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.15849996262796E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.95850000053832E-07 |
| Normal-vs-Stage2 |
2.193900E-02 |
| Normal-vs-Stage3 |
3.813800E-04 |
| Normal-vs-Stage4 |
8.044300E-04 |
| Stage1-vs-Stage2 |
7.158200E-01 |
| Stage1-vs-Stage3 |
2.768600E-01 |
| Stage1-vs-Stage4 |
9.281700E-03 |
| Stage2-vs-Stage3 |
2.491400E-01 |
| Stage2-vs-Stage4 |
7.599800E-03 |
| Stage3-vs-Stage4 |
8.923600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.44779998890021E-10 |
| Normal-vs-AfricanAmerican |
2.603800E-04 |
| Normal-vs-Asian |
1.732350E-01 |
| Caucasian-vs-AfricanAmerican |
5.415200E-01 |
| Caucasian-vs-Asian |
5.441400E-01 |
| AfricanAmerican-vs-Asian |
4.267000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.14750045208257E-10 |
| Normal-vs-Female |
3.71160000000037E-05 |
| Male-vs-Female |
4.876200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.045600E-04 |
| Normal-vs-Extreme_Weight |
9.01710039968862E-10 |
| Normal-vs-Obese |
3.25670000000944E-06 |
| Normal-vs-Extreme_Obese |
1.281800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.081400E-01 |
| Normal_Weight-vs-Obese |
4.177200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.529200E-01 |
| Extreme_Weight-vs-Obese |
5.846200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.643200E-01 |
| Obese-vs-Extreme_Obese |
8.009600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.375000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.4831000000326E-06 |
| Normal-vs-Age(61-80Yrs) |
1.64979999661696E-08 |
| Normal-vs-Age(81-100Yrs) |
1.654350E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.028140E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.902600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.761900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.238400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.071400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.907400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.87910004118197E-09 |
| Normal-VS-Type2 PRCC |
1.236270E-03 |
| Normal-VS-KIRP CIMP |
6.39559999999761E-05 |
| Normal-VS-Unclassified PRCC |
3.522400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.660400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.58599999999987E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.982400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.20319999999897E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
5.476400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.239500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62879999998644E-06 |
| Normal-vs-N1 |
5.95079999999859E-05 |
| Normal-vs-N2 |
7.138500E-02 |
| N0-vs-N1 |
5.426000E-02 |
| N0-vs-N2 |
1.144230E-01 |
| N1-vs-N2 |
6.747000E-01 |
|
|
